Literature DB >> 14660728

When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry.

Prasad V S V Neti1, Roger W Howell.   

Abstract

UNLABELLED: To varying degrees, radiopharmaceuticals are distributed nonuniformly in tissue. At a macroscopic level, the radiopharmaceutical may appear to be uniformly distributed throughout the tissue. However, on closer inspection, not all cells in the tissue may be labeled with the radiopharmaceutical. Furthermore, the radioactivity in the cells may be localized only in certain compartments within the cell. This work uses a cell culture model to examine the impact of nonuniformity at the multicellular level on the lethal effects of (131)I.
METHODS: A 3-dimensional tissue culture model was used to investigate the biologic effects of nonuniform distributions of (131)I in a large population of mammalian cells. Chinese hamster V79 cells were labeled with (131)I-iododeoxyuridine ((131)IdU), mixed with unlabeled cells, and multicellular clusters (4 x 10(6) cells) were formed by gentle centrifugation. Thus, the labeled cells were randomly located in the cluster to achieve a uniform distribution of radioactivity at the macroscopic level, yet nonuniform at the multicellular level. The clusters were assembled as described and then maintained at 10.5 degrees C for 72 h to allow (131)I decays to accumulate. The clusters were then dismantled and the cells were plated for colony formation.
RESULTS: When 100% of the cells were labeled, the surviving fraction of cells in the cluster was exponentially dependent on the cluster activity down to 0.1% survival. In contrast, when 10% of the cells were labeled, it was observed that the survival fraction begins to saturate at about 1% survival. Absorbed-dose estimates reveal that the mean lethal cluster dose is 4.5, 5.7, and 6.4 Gy for 100%, 10%, and 1% labeling, respectively.
CONCLUSION: These data indicate that when the distribution of (131)I is uniform at the macroscopic level, but nonuniform at the multicellular level, the mean absorbed dose to a tissue element may not be a suitable quantity for use in predicting biologic effect. Rather, cellular and multicellular dosimetry approaches may be necessary to predict the biologic effects of incorporated (131)I.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660728      PMCID: PMC2933742     

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  30 in total

1.  Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model.

Authors:  A Bishayee; D V Rao; R W Howell
Journal:  Radiat Res       Date:  1999-07       Impact factor: 2.841

2.  Localized beta dosimetry of 131I-labeled antibodies in follicular lymphoma.

Authors:  T E Hui; D R Fisher; O W Press; J F Eary; J N Weinstein; C C Badger; I D Bernstein
Journal:  Med Phys       Date:  1992 Jan-Feb       Impact factor: 4.071

3.  Microdosimetry of internal sources.

Authors:  W C Roesch
Journal:  Radiat Res       Date:  1977-06       Impact factor: 2.841

4.  Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model.

Authors:  A Bishayee; H Z Hill; D Stein; D V Rao; R W Howell
Journal:  Radiat Res       Date:  2001-02       Impact factor: 2.841

5.  Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210.

Authors:  A Bishayee; D V Rao; L G Bouchet; W E Bolch; R W Howell
Journal:  Radiat Res       Date:  2000-04       Impact factor: 2.841

6.  Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography.

Authors:  P L Roberson; D J Buchsbaum; D B Heidorn; R K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

7.  131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.

Authors:  V K Langmuir; J K McGann; F Buchegger; R M Sutherland
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

8.  Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.

Authors:  V R Narra; R W Howell; R S Harapanhalli; K S Sastry; D V Rao
Journal:  J Nucl Med       Date:  1992-12       Impact factor: 10.057

9.  Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides.

Authors:  R S Harapanhalli; V R Narra; V Yaghmai; M T Azure; S M Goddu; R W Howell; D V Rao
Journal:  Radiat Res       Date:  1994-07       Impact factor: 2.841

Review 10.  The radiobiology of targeted radiotherapy.

Authors:  T E Wheldon; J A O'Donoghue
Journal:  Int J Radiat Biol       Date:  1990-07       Impact factor: 2.694

View more
  10 in total

Review 1.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

2.  Biological response to nonuniform distributions of (210)Po in multicellular clusters.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  Radiat Res       Date:  2007-09       Impact factor: 2.841

3.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

4.  Flow cytometry-assisted Monte Carlo simulation predicts clonogenic survival of cell populations with lognormal distributions of radiopharmaceuticals and anticancer drugs.

Authors:  John M Akudugu; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2011-12-09       Impact factor: 2.694

5.  Modeling multicellular response to nonuniform distributions of radioactivity: differences in cellular response to self-dose and cross-dose.

Authors:  Roger W Howell; Prasad V S V Neti
Journal:  Radiat Res       Date:  2005-02       Impact factor: 2.841

6.  Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Authors:  Roger W Howell; Didier Rajon; Wesley E Bolch
Journal:  Int J Radiat Biol       Date:  2011-11-30       Impact factor: 2.694

7.  Induction of lethal bystander effects in human breast cancer cell cultures by DNA-incorporated Iodine-125 depends on phenotype.

Authors:  John M Akudugu; Edouard I Azzam; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2012-05-16       Impact factor: 2.694

8.  Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

9.  Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival.

Authors:  Giulia Tamborino; Julie Nonnekens; Marijke De Saint-Hubert; Lara Struelens; Danny Feijtel; Marion de Jong; Mark W Konijnenberg
Journal:  J Nucl Med       Date:  2021-04-09       Impact factor: 11.082

10.  What is the Role of the Bystander Response in Radionuclide Therapies?

Authors:  Darren Brady; Joe M O'Sullivan; Kevin M Prise
Journal:  Front Oncol       Date:  2013-08-19       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.